Clinical Trial Update: Stem Cell Therapy for Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating stem cell therapy for Type 2 Diabetes Mellitus, sponsored by Cellonis Biotechnology Co. Ltd.; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Cellonis Stem Cell Therapy

Snippet

Sponsor: Cellonis Biotechnology Co. Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN